Cargando…
Significant Reduction of Elevated Triglycerides and Liver Fibrosis in Diabetic Dyslipidemia with Saroglitazar: A Case Report
Metabolic disorders are characterized by pathologies like visceral adiposity, hypertension, type 2 diabetes mellitus (T2DM), dyslipidemia, impaired glucose tolerance, fatty liver, and so on, with insulin resistance being the main contributing factor. Insulin resistance and diabetes mellitus are comm...
Autores principales: | Roy, Sayak, Ghosh, Abhijnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910614/ https://www.ncbi.nlm.nih.gov/pubmed/31886093 http://dx.doi.org/10.7759/cureus.6361 |
Ejemplares similares
-
Clinical Case Series of Decrease in Shear Wave Elastography Values in Ten Diabetic Dyslipidemia Patients Having NAFLD with Saroglitazar 4 mg: An Indian Experience
por: Roy, Sayak
Publicado: (2020) -
Switch-over Study with Fast-acting Insulin Aspart Showing Lower Glycemic Variability in Type 2 Diabetics with Stage 4 Chronic Kidney Disease: A Case Series
por: Roy, Sayak, et al.
Publicado: (2019) -
Epidemiological Determinants of COVID-19-Related Patient Outcomes in Different Countries and Plan of Action: A Retrospective Analysis
por: Roy, Sayak, et al.
Publicado: (2020) -
The Effects of Dyslipidemia in Subclinical Hypothyroidism
por: Hussain, Azhar, et al.
Publicado: (2019) -
Dyslipidemia Among Patients With Type 1 Diabetes and Its Associated Factors in Saudi Arabia: An Analytical Cross-Sectional Study
por: Alrasheed, Abdullah A
Publicado: (2022)